Get In Touch
Have any questions or comments about the content you see on this page?
The Makers are the ones charged with manufacturing RNAi therapeutics. Since RNAi therapeutics are a new class of medicines, there was no set of blueprints to follow but rather the Makers needed to devise solutions for manufacturing, quality control and supply chain that were new to both Alnylam and the pharmaceutical industry.
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.Proceed to Site